600557 康缘药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.3268.2899.5769.5927.568
总资产报酬率 ROA (%)2.9265.5606.6386.7815.282
投入资产回报率 ROIC (%)4.2658.1959.3149.0636.873

边际利润分析
销售毛利率 (%)69.46573.21774.27772.09671.906
营业利润率 (%)11.0979.8659.47410.4539.620
息税前利润/营业总收入 (%)10.63010.0159.19910.0419.222
净利润/营业总收入 (%)8.8669.7739.13010.1578.890

收益指标分析
经营活动净收益/利润总额(%)79.49676.97190.39291.82794.374
价值变动净收益/利润总额(%)1.9385.3333.3020.9421.236
营业外收支净额/利润总额(%)-2.6950.064-2.859-2.040-6.920

偿债能力分析
流动比率 (X)1.9981.7591.9962.0941.978
速动比率 (X)1.7291.4951.8241.9021.746
资产负债率 (%)27.11331.87730.19127.39625.678
带息债务/全部投入资本 (%)-2.227-2.011-1.6942.9694.527
股东权益/带息债务 (%)-4,425.793-4,901.201-5,850.6243,213.4042,064.423
股东权益/负债合计 (%)257.965205.052227.604255.353278.546
利息保障倍数 (X)-60.70569.751-760.238-49.43941.010

营运能力分析
应收账款周转天数 (天)58.41954.31651.01460.41383.245
存货周转天数 (天)185.988153.52999.693100.950125.488